FDA Warning Letter Breakdown: Testing the Line Between Consumer Wellness Claims and Regulated Physiologic Measurement Functions in Wearables The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling How different peptide therapies may affect your body Prenuvo blog